Anita Dushyanth
Stock Analyst at Berenberg
(2.58)
# 2,142
Out of 5,123 analysts
4
Total ratings
75%
Success rate
15.74%
Average return
Main Sectors:
Stocks Rated by Anita Dushyanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Initiates: Buy | $20 | $20.51 | -2.49% | 1 | Apr 27, 2022 | |
| SERA Sera Prognostics | Initiates: Buy | $13 | $2.32 | +460.34% | 1 | Apr 27, 2022 | |
| BTAI BioXcel Therapeutics | Initiates: Buy | $1,200 | $1.37 | +87,491.24% | 1 | Apr 9, 2021 | |
| PCRX Pacira BioSciences | Initiates: Buy | $93 | $20.36 | +356.78% | 1 | Apr 9, 2021 |
UroGen Pharma
Apr 27, 2022
Initiates: Buy
Price Target: $20
Current: $20.51
Upside: -2.49%
Sera Prognostics
Apr 27, 2022
Initiates: Buy
Price Target: $13
Current: $2.32
Upside: +460.34%
BioXcel Therapeutics
Apr 9, 2021
Initiates: Buy
Price Target: $1,200
Current: $1.37
Upside: +87,491.24%
Pacira BioSciences
Apr 9, 2021
Initiates: Buy
Price Target: $93
Current: $20.36
Upside: +356.78%